RxDoctor Payments Data

Emily Daugherty, MD

Radiation Oncology · Cincinnati, OHNPI 1285073569

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,000 of the $2,357 with a category attached, or 84.9%. Siemens Medical Solutions USA, Inc. accounts for 87.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $2,066 and has fallen 97.8% since, to $46 in 2025.

$2,357in general payments, 2019–2025

Across 11 payments — averaging $214.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$2K
  • Intuitive Surgical$93
  • Varian Medical Systems, Inc.$63
  • Johnson & Johnson$31
  • AstraZeneca$27
  • E.r. Squibb & Sons, L.L.C.$23
  • plus $55 from 3 others
$211,070in research payments, 2019–2025

Across 10 payments — averaging $21,107 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$188K
  • E.r. Squibb & Sons, L.L.C.$23K

What the payments were for

  • Speaking & faculty fees$2,00085%
  • Food & beverage$35715%

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,357 in reported general payments places this provider in the 80th percentile of 255 radiation oncology providers in Ohio.

See all radiation oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$91,863
Medicare patients
159
Services billed
975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl11$363

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →